Patients should be counselled about: Proper injection technique and storage requirements Recognition of adverse effects requiring medical attention The importance of continuing lifestyle modifications alongside medication Regular monitoring of blood glucose, HbA1c, and renal function When to seek urgent medical care (severe abdominal pain, persistent vomiting/diarrhoea with dehydration, sudden visual changes) Patients can report suspected side effects directly to the MHRA through the Yellow Card Scheme (yellowcard.mhra.gov.uk) as well as discussing them with their healthcare provider
FDA priority reviews continue to shorten approval cycles, as seen in semaglutides 2025 chronic kidney disease indication and tirzepatides 2024 obstructive sleep apnea approval
Add ashwagandha if chronically stressed
What we know We know semaglutide reduces B12 absorption
Thambiayya K, Wasserloos K, Kagan VE, Stoyanovsky D, Pitt BR
Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development